Trial intelligence / Profile preview

Randomized open-label crossover study of mosapride in healthy Thai volunteers

TCTR20161125001Phase 1Not yet recruiting

Sponsor
International Bio Service
Start
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of mosapride (2 arms), sponsored by International Bio Service. Primary endpoint: Rate and extent of absorption. Planned start Feb 2017; status: not yet recruiting.

02

Drugs

mosapride

Beyond the preview

Go deeper on TCTR20161125001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20161125001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call